7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Neuraxis Inc.
(NYSE MKT:NRXS) 

NRXS stock logo

NeurAxis, Inc. operates as a neuromodulation therapy device company in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome healthcare ...

Founded: 2011
IPO Price: $6 (Aug 09, 2023)
Full Time Employees: 17
Sector: Biotechnology
Industry: Healthcare

Share this website to your friends
Neuraxis Days Payable Outstanding ttm (DPO)
202309 202310 202311 202312 202401 202402 202403 202404 096.49192.98289.47385.96482.45578.94675.43
Neuraxis Days Receivable Outstanding ttm (DSO)
202309 202310 202311 202312 202401 202402 202403 202404 02.725.438.1510.8613.5816.319.01
Neuraxis Days Inventory Outstanding ttm (DIO)
202309 202310 202311 202312 202401 202402 202403 202404 05.8811.7617.6423.5229.435.2841.16
Neuraxis Op Cashflow Per Share ttm
202309 202310 202311 202312 202401 202402 202403 202404 -1.18-1.01-0.84-0.67-0.51-0.34-0.170
Neuraxis Free Cashflow Per Share ttm
202309 202310 202311 202312 202401 202402 202403 202404 -1.21-1.04-0.86-0.69-0.52-0.35-0.170
Neuraxis Cash Per Share ttm
202309 202310 202311 202312 202401 202402 202403 202404 00.030.060.090.120.150.180.21
Neuraxis P/S ratio ttm
202309 202310 202311 202312 202401 202402 202403 202404 01.012.023.034.045.056.067.08
Neuraxis (GAAP) P/E ratio ttm
202309 202310 202311 202312 202401 202402 202403 202404 -7.2-6.17-5.14-4.11-3.09-2.06-1.030
Neuraxis P/B ratio ttm
202309 202310 202311 202312 202401 202402 202403 202404 -26.73-22.91-19.09-15.27-11.45-7.64-3.820
No extra charts and metrics for this ticker.